New registry aims to uncover gender gaps in heart valve care

NCT ID NCT07196930

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 2 times

Summary

This registry will track 800 adults with valvular heart disease to see if women and men receive different diagnosis, treatment, and follow-up care. Researchers will compare how quickly each group gets guideline-recommended therapies and whether gender, age, or ethnicity affect outcomes. The goal is to identify and reduce unfair disparities in heart valve disease management.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to
If successful, this registry could highlight gaps in care for women with valve disease and guide fairer treatment guidelines.
What could go wrong
This is an observational registry, not a treatment trial. It can show patterns but cannot prove what causes them or improve care directly.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DISPARITIES are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Aswan Heart Centre

    RECRUITING

    Aswān, Egypt

  • University of Lisbon

    RECRUITING

    Lisbon, Portugal

More trials for these conditions

Other studies related to the condition(s) this trial covers.